Skip to main content
SpringerLink
Log in
Book cover

Interpretation of Endoscopic Biopsy - Gastritis, Gastropathies and Beyond pp 149–173Cite as

Morphological Aspect of Gastric Carcinomas

  • Chapter
  • First Online:

  • 759 Accesses

Abstract

Histological classification based on the different histomorphology has remained the basis for prognosticating and further molecular classification of tumours. Recent WHO classification has recognized new entities and are included in the specialized group of tumours.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Gullo I, Carneiro F, Oliveira C, et al. Heterogeneity in gastric cancer: from pure morphology to molecular classifications. Pathobiology. 2018;85:50–63.

    Article  PubMed  Google Scholar 

  2. Hu B, El Hajj N, Sittler S, et al. Gastric cancer: classification, histology and application of molecular pathology. J Gastrointest Oncol. 2012;3:251–61.

    PubMed  PubMed Central  Google Scholar 

  3. Gao JP, Xu W, Liu WT, et al. Tumour heterogeneity of gastric cancer: from the perspective of tumour-initiating cell. World J Gastroenterol. 2018;24:2567–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Welch DR. Tumor heterogeneity – a ‘contemporary concept’ founded on historical insights and predictions. Cancer Res. 2016;76:4–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Ho SWT, Tan P. Dissection of gastric cancer heterogeneity for precision oncology. Cancer Sci. 2019;110:3405–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Gerlinger M, Rowan AJ, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multi-region sequencing. N Engl J Med. 2012;366:883–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Junttila MR, de Sauvage FJ. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 2013;501(7467):346–54.

    Article  CAS  PubMed  Google Scholar 

  8. Tatematsu M, Tsukamoto T, Inada K. Stem cells and gastric cancer: role of gastric and intestinal mixed intestinal metaplasia. Cancer Sci. 2003;94:135–41.

    Article  CAS  PubMed  Google Scholar 

  9. Li K, Dan Z, Nie YQ. Gastric cancer stem cells in gastric carcinogenesis, progression, prevention and treatment. World J Gastroenterol. 2014;20:5420–6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Nakamura T, Yao T, Kabashima A, et al. Loss of phenotypic expression is related to tumour progression in early gastric differentiated adenocarcinoma. Histopathol. 2005;47:357–67.

    Article  CAS  Google Scholar 

  11. Fenoglio-Preiser CM, Carneiro F, Correa P, et al. Gastric carcinoma. In: Hamilton SR, Aaltonen LA, editors. World Health Organization classification of tumors. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press; 2000. p. 37–68.

    Google Scholar 

  12. Parsonnet FG, Vandersteen DP. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991;325:1127–271.

    Article  CAS  PubMed  Google Scholar 

  13. Group IARC (1994) Monographs on the evaluation of the carcinogenic risks to humans. Scistosomes Liver Flukes and Helicobacter pylori. pp 177–241

    Google Scholar 

  14. Danesh J. Is Helicobacter pylori infection a cause of gastric neoplasia. Cancer Surv. 1999;33:263–89.

    Google Scholar 

  15. Keller G, Rudelius M, Vogelsang H, et al. Microsatellite instability and loss of heterozygosity in gastric carcinoma in comparison to family history. Am J Pathol. 1998;152:1281–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Varley JM, McGown G, Thorncroft M, et al. An extended Li-Fraumeni kindred with gastric carcinoma and a codon 175 mutation in TP53. J Med Genet. 1995;32:942–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. La Vecchia C, Negri E, Franceschi S, et al. Family history and the risk of stomach and colorectal cancer. Cancer. 1992;70:50–5.

    Article  PubMed  Google Scholar 

  18. Sokoloff B. Predisposition to cancer in the Bonaparte family. Am J Surg. 1938;40:673–8.

    Article  Google Scholar 

  19. Lauren P. The two histologic main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49.

    Article  CAS  PubMed  Google Scholar 

  20. Fitzgerald RC, Caldas C. E-cadherin mutations and hereditary gastric cancer: prevention by resection? Dig Dis. 2002;20:23–31.

    Article  CAS  PubMed  Google Scholar 

  21. Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature. 1998;392:402–5.

    Article  CAS  PubMed  Google Scholar 

  22. Guilford P, Humar B, Blair V. Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice. Gastric Cancer. 2010;13:1–10.

    Article  CAS  PubMed  Google Scholar 

  23. Becker KF, Atkinson MJ, Reich U, et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res. 1994;54:3845–52.

    CAS  PubMed  Google Scholar 

  24. Machado JC, Soares P, Carneiro F, et al. E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. Lab Invest. 1999;79:459–65.

    CAS  PubMed  Google Scholar 

  25. Perl AK, Wilgenbus P, Dahl U, et al. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature. 1998;392:190–3.

    Article  CAS  PubMed  Google Scholar 

  26. Yoshiura K, Kanai Y, Ochiai A, et al. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci U S A. 1995;92:7416–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Guilford PJ, Hopkins JB, Grady WM, et al. E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat. 1999;14:249–55.

    Article  CAS  PubMed  Google Scholar 

  28. Ghatak S, Chakraborty P, Sarkar SR, et al. Novel APC gene mutations associated with protein alteration in diffuse type gastric cancer. BMC Med Genet. 2017;18:61–72.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  29. Clements WM, Wang J, Sarnaik A, et al. β-catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res. 2002;62:3503–6.

    CAS  PubMed  Google Scholar 

  30. Berx G, Becker KF, Hofler H, et al. Mutations of the human E-cadherin (CDH1) gene. Hum Mutat. 1998;2:226–37.

    Article  Google Scholar 

  31. Chan AO, Luk JM, Hui WM, et al. Molecular biology of gastric carcinoma: from laboratory to bedside. J Gastroenterol Hepatol. 1999;4:1150–60.

    Article  Google Scholar 

  32. Guilford P, Blair V, More H, et al. A short guide to hereditary diffuse gastric cancer. Hered Cancer Clin Pract. 2007;5:183–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Gayther SA, Gorringe KL, Ram SJ, et al. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res. 1998;58:4086–9.

    CAS  PubMed  Google Scholar 

  34. Richards FM, McKee SA, Rajpar MH, et al. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum Mol Genet. 1999;8:607–10.

    Article  CAS  PubMed  Google Scholar 

  35. Salahshor S, Hou H, Diep CB, et al. A germline E-cadherin mutation in a family with gastric and colon cancer. Int J Mol Med. 2001;8:439–43.

    CAS  PubMed  Google Scholar 

  36. Lee TL, Leung WK, Chan MW, et al. Detection of gene promoter hypermethylation in the tumour and serum of patients with gastric carcinoma. Clin Cancer Res. 2002;8:1761–6.

    CAS  PubMed  Google Scholar 

  37. Grady WM, Willis J, Guilford PJ, et al. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet. 2000;26:16–7.

    Article  CAS  PubMed  Google Scholar 

  38. Machado JC, Oliveira C, Carvalho R, et al. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene. 2001;20:1525–8.

    Article  CAS  PubMed  Google Scholar 

  39. Wilcox R, Perpich M, Noffsinger A, et al. Hereditary diffuse gastric cancer: multidisciplinary case report with review of the literature. Patholog Res Int. 2011; https://doi.org/10.4061/2011/845821

  40. Barber M, Murrell A, Ito Y, et al. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer. J Pathol. 2008;216:295–306.

    Article  CAS  PubMed  Google Scholar 

  41. Graziano F, Humar B, Guilford P. The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice. Ann Oncol. 2003;14:1705–13.

    Article  CAS  PubMed  Google Scholar 

  42. Caldas C, Carneiro F, Lynch HT, et al. Familial gastric cancer: overview and guidelines for management. J Med Genet. 1999;36:873e80.

    Google Scholar 

  43. Oliveira C, Bordin MC, Grehan N, et al. Screening E-cadherin in gastric cancer families reveals germ-line mutations only in hereditary diffuse gastric cancer kindred. Hum Mutat. 2002;19:510e17.

    Article  Google Scholar 

  44. Pharoah PD, Guilford P, Caldas C. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology. 2001;121:1348–53.

    Article  CAS  PubMed  Google Scholar 

  45. Chan JK, Wong CS. Loss of E-cadherin is the fundamental defect in diffuse-type gastric carcinoma and infiltrating lobular carcinoma of the breast. Adv Anat Pathol. 2001;8:165–72.

    Article  CAS  PubMed  Google Scholar 

  46. WHO Classification of Tumours Editorial Board (2019) WHO classification of tumours: digestive system tumours, 5th ed., vol 1. pp 85–92

    Google Scholar 

  47. 90th Annual Meeting of the Japanese Gastric Cancer Association, Kyoto, Japan (2018) Reports of national registration analysis results: surgical cases 2009

    Google Scholar 

  48. Dawson H, Novotny A, Becker K, et al. Macroscopy predicts tumour progression in gastric cancer: a retrospective patho-historical analysis based on Napoleon Bonaparte’s autopsy report. Dig Liver Dis. 2016;48:1378–85.

    Article  PubMed  Google Scholar 

  49. Arai T, Sakurai U, Sawabe M, et al. Frequent microsatellite instability in papillary and solid-type, poorly differentiated adenocarcinomas of the stomach. Gastric Cancer. 2013;16:505–12.

    Article  CAS  PubMed  Google Scholar 

  50. Ghotli ZA, Serra S, Chetty R. Clear cell (glycogen rich) gastric adenocarcinoma: a distinct tubulo-papillary variant with a predilection for the cardia/gastro-oesophageal region. Pathology. 2007;39:466–9.

    Article  CAS  PubMed  Google Scholar 

  51. Japanese Gastric Cancer Association (2011) Japanese classification of gastric carcinoma: 3rd English ed. Gastric Cancer 14:101–112

    Google Scholar 

  52. Huang Q, Zou X. Clinicopathology of early gastric carcinoma: an update for pathologists and gastroenterologists. Gastrointest Tumours. 2017;3:115–24.

    Article  Google Scholar 

  53. Yu H, Fang C, Chen L, et al. Worse prognosis in papillary, compared to tubular, early gastric carcinoma. J Cancer. 2017;8:117–23.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Marrelli D, Pedrazzani C, Morgagni D, et al. Changing clinical and pathological features of gastric cancer over time. Bri J Surg. 2011;98:1273–83.

    Article  CAS  Google Scholar 

  55. Wu H, Rusiecki JA, Zhu K, et al. Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiol Biomarkers Prev. 2009;18:1945–52.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Lauwers GY, Carneiro F, Graham DY, et al. Gastric carcinoma. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumours of the digestive system. 4th ed. Lyon: IARC Press; 2010. p. 48–58.

    Google Scholar 

  57. Kwon CH, Kim YK, Lee S, et al. Gastric poorly cohesive carcinoma: a correlative study of mutational signatures and prognostic significance based on histopathological subtypes. Histopathol. 2018;72:556–68.

    Article  Google Scholar 

  58. Mariette C, Carneiro F, Grabsch HI, et al. Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma. Gastric Cancer. 2019;22(1):1–9.

    Article  CAS  PubMed  Google Scholar 

  59. Liu K, Wan J, Bei Y, et al. Prognostic impact of different histological types on gastric adenocarcinoma: a surveillance, epidemiology, and end results database analysis. Pathol Oncol Res. 2017;23:881–7.

    Article  PubMed  Google Scholar 

  60. Voron T, Messager M, Duhamel A, et al. Is signet-ring cell carcinoma a specific entity among gastric cancers? Gastric Cancer. 2015;19:1027–40.

    Article  PubMed  CAS  Google Scholar 

  61. Jiang H, Zhang H, Tian L, et al. The difference in clinic-pathological features between signet ring cell carcinoma and gastric mucinous adenocarcinoma. Tumor Biol. 2013;34:2625–31.

    Article  CAS  Google Scholar 

  62. Jian-Hui C, Shi-Rong C, Hui W, et al. Gastric mucinous cancer histology: clinicopathological characteristics and prognostic value. Gastroenterol Res Pract. 2016;2016:8947505. (Open access)

    Article  PubMed  Google Scholar 

  63. Yin C, Li D, Sun Z, et al. Clinicopathologic features and prognosis analysis of mucinous gastric carcinoma. Med Oncol. 2012;29:864–70.

    Article  PubMed  Google Scholar 

  64. Jass JR, Sobin LH, Watanabe H. The World Health Organization’s histologic classification of gastrointestinal tumors. A commentary on the second edition. Cancer. 1990;66:2162–7.

    Article  CAS  PubMed  Google Scholar 

  65. Bosman FT, Carneiro F, Hruban RH. WHO classification of tumours of the digestive system, vol. 4. Lyon: International Agency for Research on Cancer; 2010.

    Google Scholar 

  66. Hsu JT, Wang CW, Le PH, et al. Clinicopathological characteristics and outcomes in stage I-III mucinous gastric adenocarcinoma: a retrospective study at a single medical center. World J Surg Oncol. 2016;14:123.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Shi C, Yang B, Chen Q, et al. Retrospective analysis of adjuvant intraperitoneal chemotherapy effect prognosis of resectable gastric cancer. Oncology. 2011;80:289–95.

    Article  CAS  PubMed  Google Scholar 

  68. Choi JS, Kim MA, Lee HE, et al. Mucinous gastric carcinomas: clinicopathologic and molecular analyses. Cancer. 2009;115:3581–90.

    Article  CAS  PubMed  Google Scholar 

  69. Albarello L, Pecciarini L, Doglioni C. HER2 testing in gastric cancer. Adv Anat Pathol. 2011;18:53–9.

    Article  CAS  PubMed  Google Scholar 

  70. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th ed.). Gastric Cancer. 2020; https://doi.org/10.1007/s10120-020-01042-y. Online ahead of print

  71. Thrumurthy SG, Chaudry MA, Hochhauser D, et al. The diagnosis and management of gastric cancer. BMJ. 2013;347:f6367.

    Article  PubMed  Google Scholar 

  72. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 15th ed. Kanehara Shuppan; 2017.

    Google Scholar 

  73. Nagtegaal ID, Odze RD, Klimstra D, et al. The 2019 WHO classification of tumours of the digestive system. Histopathol. 2020;76:182–8.

    Article  Google Scholar 

  74. Stelzner S, Emmrich P. The mixed type in Laurén’s classification of gastric carcinoma. Histologic description and biologic behaviour. Gen Diagn Pathol. 1997;143:39–48.

    CAS  PubMed  Google Scholar 

  75. Horiuchi Y, Fujisaki J, Yamamoto N, et al. Undifferentiated-type predominant mixed-type early gastric cancer is a significant risk factor for requiring additional surgeries after endoscopic submucosal dissection. Sci Rep. 2020;10:6748.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Horiuchi Y, Ida S, Yamamoto N, et al. Feasibility of further expansion of the indications for endoscopic submucosal dissection in undifferentiated-type early gastric cancer. Gastric Cancer. 2020;23:285–92.

    Article  CAS  PubMed  Google Scholar 

  77. Yamada T, Yoshikawa T, Taguri M, et al. The survival difference between gastric cancer patients from the UK and Japan remains after weighted propensity score analysis considering all background factors. Gastric Cancer. 2016;19:479–89.

    Article  PubMed  Google Scholar 

  78. Barros-Silva J, Leitão D, Afonso L, et al. Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients. Br J Cancer. 2009;100:487–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Carvalho B, Buffart TE, Reisc RM, et al. Mixed gastric carcinomas show similar chromosomal aberrations in both their diffuse and glandular components by microarray – comparative genomic hybridisation (array CGH). Cell Oncol. 2006;28:283–94.

    CAS  PubMed  PubMed Central  Google Scholar 

  80. Kim MA, Jung EJ, Lee HS, et al. Evaluation of HER-2 gene status in gastric carcinoma using immunohistochemistry, fluorescence in situ hybridization, and real-time quantitative polymerase chain reaction. Hum Pathol. 2007;38:1386–93.

    Article  CAS  PubMed  Google Scholar 

  81. Lim H, Park YS, Lee JH, et al. Features of gastric carcinoma with lymphoid stroma associated with Epstein–Barr virus. Clin Gastroenterol Hepatol. 2015;13:1738–44.

    Article  PubMed  Google Scholar 

  82. Watanabe H, Enjoji M, Imai T. Gastric carcinoma with lymphoid stroma: its morphologic characteristics and prognostic correlations. Cancer. 1976;38:232–443.

    Article  CAS  PubMed  Google Scholar 

  83. Burke AP, Yen TS, Shekitka KM, et al. Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod Pathol. 1990;3:377–80.

    CAS  PubMed  Google Scholar 

  84. Nakamura S, Ueki T, Yao T, et al. Epstein-Barr virus in gastric carcinoma with lymphoid stroma. Special reference to its detection by the polymerase chain reaction and in situ hybridization in 99 tumours, including a morphologic analysis. Cancer. 1994;73:2239–49.

    Article  CAS  PubMed  Google Scholar 

  85. MacCarty WC, Mahle AE. Relation of differentiation and lymphocytic infiltration to postoperative longevity in gastric carcinoma. J Lab Clin Med. 1922;6:473–80.

    Google Scholar 

  86. Song HJ, Srivastava A, Lee J, et al. Host inflammatory response predicts survival of patients with Epstein-Barr virus-associated gastric carcinoma. Gastroenterol. 2010;139:84–92.e82.

    Article  Google Scholar 

  87. Grogg KL, Lohse CM, Pankratz VS, et al. Lymphocyte-rich gastric cancer: associations with Epstein-Barr virus, microsatellite instability, histology, and survival. Mod Pathol. 2003;16:641–51.

    Article  PubMed  Google Scholar 

  88. Hamazaki M, Sawayama K, Kuriya T. Stomach cancer with lymphoid stroma. J Karyopathol. 1968;12:115–20.

    Google Scholar 

  89. Lee JH, Kim SH, Han SH, et al. Clinicopathological and molecular characteristics of Epstein–Barr virus-associated gastric carcinoma: a meta-analysis. J Gastroenterol Hepatol. 2009;24:354–65.

    Article  PubMed  Google Scholar 

  90. Cheng N, Hui DY, Liu Y, et al. Is gastric lymphoepithelioma-like carcinoma a special subtype of EBV-associated gastric carcinoma? New insight based on clinicopathological features and EBV genome polymorphisms. Gastric Cancer. 2015;18:246–55.

    Article  CAS  PubMed  Google Scholar 

  91. Oliveira C, Seruca R, Seixas M, et al. The clinicopathological features of gastric carcinomas with microsatellite instability may be mediated by mutations of different “target genes”: a study of the TGFbeta RII, IGFII R, and BAX genes. Am J Pathol. 1998;153:1211–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Hissong E, Ramrattan G, Zhang P, et al. Gastric carcinomas with lymphoid stroma: an evaluation of the histopathologic and molecular features. Am J Surg Pathol. 2018;42:453–62.

    Article  PubMed  Google Scholar 

  93. Liu X, Cheng Y, Sheng W, et al. Analysis of clinicopathologic features and prognostic factors in hepatoid adenocarcinoma of the stomach. Am J Surg Pathol. 2010;34:1465–71.

    Article  PubMed  Google Scholar 

  94. Lin CY, Yeh HC, Hsu CM, et al. Clinicopathological features of gastric hepatoid adenocarcinoma. Biom J. 2015;38:65–9.

    Google Scholar 

  95. Zhao M, Sun L, Lai JZ, et al. Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: an immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1. Pathol Res Pract. 2018;214:1707–12.

    Article  CAS  PubMed  Google Scholar 

  96. Ushiku T, Shinozaki A, Shibahara J, et al. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma. Am J Surg Pathol. 2010;34:533–40.

    Article  PubMed  Google Scholar 

  97. Liu X, Sheng W, Wang Y. An analysis of clinicopathological features and prognosis by comparing hepatoid adenocarcinoma of the stomach with AFP-producing gastric cancer. J Surg Oncol. 2012;106:299–303.

    Article  PubMed  Google Scholar 

  98. Chang YC, Nagasue N, Abe S, et al. Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers. Am J Gastroenterol. 1992;87:321–5.

    CAS  PubMed  Google Scholar 

  99. Bourreille J, Metayer P, Sauger F, et al. Existence d’alpha-foetoproteine au cours d’un cancer secondaire du foie d’origine gastrique. Presse Méd. 1970;78:1277–8.

    CAS  PubMed  Google Scholar 

  100. Ishikura H, Kirimoto K, Shamoto M, et al. Hepatoid adenocarcinoma of the stomach: an analysis of seven cases. Cancer. 1986;58:119–26.

    Article  CAS  PubMed  Google Scholar 

  101. Bozkaya Y, Demirci NS, Kurtipek A, et al. Clinicopathological and prognostic characteristics in patients with AFP-secreting gastric carcinoma. Mol Clin Oncol. 2017;7:267–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. Matsunou H, Konishi F, Jalal RE, et al. Alpha-fetoprotein-producing gastric carcinoma with enteroblastic differentiation. Cancer. 1994;73:534–40.

    Article  CAS  PubMed  Google Scholar 

  103. Murakami T, Yao T, Mitomi H, et al. Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases. Gastric Cancer. 2016;19:498–507.

    Article  CAS  PubMed  Google Scholar 

  104. Kodama T, Kameya T, Hirota T, et al. Production of alpha-fetoprotein, normal serum proteins, and human chorionic gonadotropin in stomach cancer: histologic and immunohistochemical analyses of 35 cases. Cancer. 1981;48:1647–55.

    Article  CAS  PubMed  Google Scholar 

  105. Govender D, Ramdial PK, Clarke B, et al. Clear cell (glycogen-rich) gastric adenocarcinoma. Ann Diagn Pathol. 2004;8:69–73.

    Article  PubMed  Google Scholar 

  106. Ghotli ZA, Serra S, Chetty R. Clear cell (glycogen rich) gastric adenocarcinoma: a distinct tubulo-papillary variant with a predilection for the cardia/gastro-oesophageal region. Pathol. 2007;39:466–9.

    CAS  Google Scholar 

  107. Lauwers GY, Carneiro F, Graham DY, et al. Gastric carcinoma. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumours of the digestive system. 4th ed. Lyon: International Agency for Research on Cancer; 2010.

    Google Scholar 

  108. Kumashiro Y, Yao T, Aishima S, et al. Hepatoid adenocarcinoma of the stomach: histogenesis and progression in association with intestinal phenotype. Hum Pathol. 2007;38:857–63.

    Article  CAS  PubMed  Google Scholar 

  109. Akazawa Y, Saito T, Hayashi T, et al. Next-generation sequencing analysis for gastric adenocarcinoma with enteroblastic differentiation: emphasis on the relationship with hepatoid adenocarcinoma. Hum Pathol. 2018;78:79–88.

    Article  CAS  PubMed  Google Scholar 

  110. Kinjo T, Taniguchi H, Kushima R, et al. Histologic and immunohistochemical analyses of α-fetoprotein-producing cancer of the stomach. Am J Surg Pathol. 2012;36:56–65.

    Article  PubMed  Google Scholar 

  111. Ushiku T, Uozaki H, Shinozaki A, et al. Glypican 3-expressing gastric carcinoma: distinct subgroup unifying hepatoid, clear-cell, and α-fetoprotein-producing gastric carcinomas. Cancer Sci. 2009;100:626–32.

    Article  CAS  PubMed  Google Scholar 

  112. Cheng Y, Du M, Wang Y, et al. Micropapillary early gastric carcinoma with distinct Clinicopathologic features, high risk for lymph node metastasis, and dismal prognosis: a multicenter Clinicopathologic study of 29 cases identified in 1890 early gastric carcinoma radical surgery. Human Path. 2019;83:149–58.

    Article  Google Scholar 

  113. Huang Q, Fang C, Shi J, et al. Differences in clinicopathology of early gastric carcinoma between proximal and distal location in 438 Chinese patients. Sci Rep. 2015;5:13439.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  114. Fang C, Shi J, Sun Q, et al. Risk factors of lymph node metastasis in early gastric carcinomas diagnosed by WHO criteria in 379 Chinese patients. J Dig Dis. 2016;17:526–37.

    Article  CAS  PubMed  Google Scholar 

  115. Eom DW, Kang GH, Han SH, et al. Gastric micropapillary carcinoma: a distinct subtype with a significantly worse prognosis in TNM stages I and II. Am J Surg Pathol. 2011;35:84–91.

    Article  PubMed  Google Scholar 

  116. Zhang Q, Ming J, Zhang S, et al. Micropapillary component in gastric adenocarcinoma: an aggressive variant associated with poor prognosis. Gastric Cancer. 2015;18:93–9.

    Article  CAS  PubMed  Google Scholar 

  117. Fujita T, Gotohda N, Kato Y, et al. Clinicopathological features of stomach cancer with invasive micropapillary component. Gastric Cancer. 2012;15:179–87.

    Article  PubMed  Google Scholar 

  118. Ohtsuki Y, Kuroda N, Yunoki S, et al. Immunohistochemical analysis of invasive micropapillary carcinoma pattern in four cases of gastric cancer. Med Mol Morphol. 2013;46:114–21.

    Article  PubMed  Google Scholar 

  119. Dobrițoiu M, Stepan AE, Vere CC, et al. Study of histopatological parameters of gastric carcinomas with micropapillary component. Curr Health Sci J. 2018;44:225–30.

    PubMed  PubMed Central  Google Scholar 

  120. Lewin E, Daroca P, Sikka S, et al. Gastric adenocarcinoma of the fundic gland type treated by endoscopic mucosal resection: a case report and review of the literature. Case Rep Pathol. 2016;2016:8646927.

    PubMed  PubMed Central  Google Scholar 

  121. Tsukamoto T, Yokoi T, Maruta S, et al. Gastric adenocarcinoma with chief cell differentiation. Pathol Int. 2007;57:517–22.

    Article  PubMed  Google Scholar 

  122. Ueyama H, Yao T, Nakashima Y, et al. Gastric adenocarcinoma of fundic gland type (chief cell predominant type): proposal for a new entity of gastric adenocarcinoma. Am J Surg Pathol. 2010;34:609–19.

    Article  PubMed  Google Scholar 

  123. Kushima R, Sekine S, Matsubara A, et al. Gastric adenocarcinoma of the fundic gland type shares common genetic and phenotypic features with pyloric gland adenoma. Path Int. 2013;63:318–25.

    Article  CAS  Google Scholar 

  124. Ueo T, Yonemasu H, Ishida T. Gastric adenocarcinoma of fundic gland type with unusual behaviour. Dig Endosc. 2014;26:293–4.

    Article  PubMed  Google Scholar 

  125. Miyazawa M, Matsuda M, Yano M, et al. Gastric adenocarcinoma of fundic gland type: five cases treated with endoscopic resection. World J Gastroenterol. 2015;21:8208–14.

    Article  PubMed  PubMed Central  Google Scholar 

  126. Tohda G, Osawa T, Asada Y. Gastric adenocarcinoma of fundic gland type: endoscopic and clinicopathological features. World J Gastrointest End. 2016;8:244–51.

    Article  Google Scholar 

  127. Singhi AD, Lazenby AJ, Montgomery EA. Gastric adenocarcinoma with chief cell differentiation: a proposal for reclassification as oxyntic gland polyp/adenoma. Am J Surg Pathol. 2012;36:1030–5.

    Article  PubMed  Google Scholar 

  128. Terada T. Well differentiated adenocarcinoma of the stomach composed of chief cell-like cells and parietal cells (Gastric adenocarcinoma of fundic gland type). Int J Clin Exp Path. 2011;4:797–8.

    Google Scholar 

  129. Benedict MA, Lauwers GY, Jain D. Gastric adenocarcinoma of the fundic gland type: update and literature review. Am J Clin Pathol. 2018;149:461–73.

    Article  PubMed  Google Scholar 

  130. Ueyama H, Matsumoto K, Nagahara A, et al. Gastric adenocarcinoma of the fundic gland type (chief cell predominant type). Endoscopy. 2014;46:153–7.

    PubMed  Google Scholar 

  131. Hidaka Y, Mitomi H, Saito T, et al. Alteration in the Wnt/𝛽-catenin signalling pathway in gastric neoplasias of fundic gland (chief cell predominant) type. Hum Pathol. 2013;44:2438–48.

    Article  CAS  PubMed  Google Scholar 

  132. Matsusaka T, Watanabe H, Enjoji M. Oat-cell carcinoma of the stomach. Fukuoka Igaku Zasshi. 1976;67:65–73.

    CAS  PubMed  Google Scholar 

  133. Wu QQ, Qiang WG, Wang F, et al. Management of primary gastric small cell carcinoma in China. Int J Clin Exp Med. 2015;8:1589–97.

    PubMed  PubMed Central  Google Scholar 

  134. Takaku H, Oka K, Naoi Y, et al. Primary advanced gastric small cell carcinoma: a case report and review of the literature. Am J Gastroenterol. 1999;94:1402–4.

    CAS  PubMed  Google Scholar 

  135. Murakami H, Rino Y, Yamanaka S, et al. Paraneoplastic neurological syndrome in a patient with gastric cancer. Gastric Cancer. 2010;13:204–8.

    Article  PubMed  Google Scholar 

  136. Fukuda T, Ohnishi Y, Nishimaki T, et al. Early gastric cancer of the small cell type. Am J Gastroenterol. 1988;83:1176–9.

    CAS  PubMed  Google Scholar 

  137. Bakogeorgos M, Kalkanis D, Katsaounis P, et al. Small cell carcinoma of the stomach: a report of two cases and a review of the literature. Mol Clin Oncol. 2018;9:11–6.

    PubMed  PubMed Central  Google Scholar 

  138. Kim KO, Lee HY, Chun SH, et al. Clinical overview of extrapulmonary small cell carcinoma. J Korean Med Sci. 2006;21:833–7.

    Article  PubMed  PubMed Central  Google Scholar 

  139. Matsubayashi H, Takagaki S, Otsubo T, et al. Advanced gastric glandular-endocrine cell carcinoma with 1-year survival after gastrectomy. Gastric Cancer. 2000;3:226–33.

    Article  PubMed  Google Scholar 

  140. Hassan MM, Phan A, Li D, et al. Risk factors associated with neuroendocrine tumors: a U.S.-based case-control study. Int J Cancer. 2008;123:867–73.

    Article  CAS  PubMed  Google Scholar 

  141. Kusayanagi S, Konishi K, Miyasaka N, et al. Primary small cell carcinoma of the stomach. J Gastroenterol Hepatol. 2003;18:743–7.

    Article  PubMed  Google Scholar 

  142. Namikawa T, Kobayashi M, Okabayashi T, et al. Primary gastric small cell carcinoma: report of a case and review of the literature. Med Mol Morphol. 2005;38:256–61.

    Article  PubMed  Google Scholar 

  143. O’Byrne KJ, Cherukuri AK, Khan MI, et al. Extrapulmonary small cell gastric carcinoma. A case report and review of the literature. Acta Oncol. 1977;36:78–80.

    Article  Google Scholar 

  144. Chejfec G, Gould VE. Malignant gastric neuroendocrinomas. Ultrastructural and biochemical characterization of their secretory activity. Hum Pathol. 1977;8:433–40.

    Article  CAS  PubMed  Google Scholar 

  145. Okita NT, Kato K, Takahari D, et al. Neuroendocrine tumors of the stomach: chemotherapy with cisplatin plus irinotecan is effective for gastric poorly-differentiated neuroendocrine carcinoma. Gastric Cancer. 2011;14:161–5.

    Article  CAS  PubMed  Google Scholar 

  146. Hirata Y, Sakamoto N, Yamamoto H, et al. Gastric carcinoid with ectopic production of ACTH and beta-MSH. Cancer. 1976;37:377–85.

    Article  CAS  PubMed  Google Scholar 

  147. Arai K, Matsuda M. Gastric small-cell carcinoma in Japan: a case report and review of the literature. Am J Clin Oncol. 1998;21:458–61.

    Article  CAS  PubMed  Google Scholar 

  148. Matsui K, Kitagawa M, Miwa A, et al. Small cell carcinoma of the stomach: a clinicopathologic study of 17 cases. Am J Gastroenterol. 1991;86:1167–75.

    CAS  PubMed  Google Scholar 

  149. Matsui K, Jin XM, Kitagawa M, et al. Clinicopathologic features of neuroendocrine carcinomas of the stomach: appraisal of small cell and large cell variants. Arch Pathol Lab Med. 1998;122:1010–7.

    CAS  PubMed  Google Scholar 

  150. Travis WD, Brambilla E, Nicholson AG, et al. On behalf of the WHO panel. The 2015 World Health Organization classification of lung tumors impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10:1243–60.

    Article  PubMed  Google Scholar 

  151. Tsuneyama K, Sasaki M, Sabit A, et al. A case report of gastric carcinosarcoma with rhabdomyosarcomatous and neuroendocrinal differentiation. Pathol Res Pract. 1999;195:93–7.

    Article  CAS  PubMed  Google Scholar 

  152. Yamazaki K. A gastric carcinosarcoma with neuroendocrine cell differentiation and undifferentiated spindle-shaped sarcoma component possibly progressing from the conventional tubular adenocarcinoma; an immunohistochemical and ultrastructural study. Virchows Arch. 2003;442:77–81.

    Article  PubMed  Google Scholar 

  153. Kuroda N, Oonishi K, Iwamura S, et al. Gastric carcinosarcoma with neuroendocrine differentiation as the carcinoma component and leiomyosarcomatous and myofibroblastic differentiation as the sarcomatous component. APMIS. 2006;114:234–8.

    Article  CAS  PubMed  Google Scholar 

  154. Haratake J, Horie A, Inoshita S. Gastric small cell carcinoma with squamous and neuroendocrine differentiation. Pathology. 1992;24:16–20.

    Article  Google Scholar 

  155. Brenner B, Tang LH, Klimstra DS, et al. Small-cell carcinomas of the gastrointestinal tract: a review. J Clin Oncol. 2004;22:2730–9.

    Article  PubMed  Google Scholar 

  156. Bartley AN, Rashid A, Fournier KF, et al. Neuroendocrine and mucinous differentiation in signet ring cell carcinoma of the stomach: evidence for a common cell of origin in composite tumors. Hum Pathol. 2011;42:1420–9.

    Article  CAS  PubMed  Google Scholar 

  157. Li AF, Li AC, Hsu CY, et al. Small cell carcinomas in gastrointestinal tract: immunohistochemical and clinicopathological features. J Clin Pathol. 2010;63:620–5.

    Article  PubMed  Google Scholar 

  158. Rindi G, Azzoni C, La Rosa S, et al. ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterol. 1999;116:532–42.

    Article  CAS  Google Scholar 

  159. Won OH, Farman J, Krishnan MN, et al. Squamous cell carcinoma of the stomach. Am J Gastroenterol. 1978;69:594–8.

    CAS  PubMed  Google Scholar 

  160. Lim SM, Jung ES, Shin SK, et al. A case of synchronous squamous cell carcinoma in the esophagus and stomach. Gut Liver. 2012;6:118–21.

    Article  PubMed  PubMed Central  Google Scholar 

  161. Dursun M, Yaldiz M, Işikdoğan A, et al. Primary squamous cell carcinoma of the stomach: a case report and review of the literature. Eur J Gastroenterol Hepatol. 2003;15:329–30.

    Article  PubMed  Google Scholar 

  162. González-Sánchez JA, Vitón R, Collantes E, et al. Primary Squamous Cell Carcinoma of the Stomach. Clin Med Insights Oncol. 2017; https://doi.org/10.1177/1179554916686076.

  163. Parks RE. Squamous neoplasms of the stomach. Am J Roentgenol Radium Ther Nucl Med. 1967;101:447–9.

    Article  CAS  PubMed  Google Scholar 

  164. Japanese classification of gastric carcinoma (2011) 3rd English ed. Gastric Cancer 14:101–112

    Google Scholar 

  165. Mingazzini PL, Barsotti P, Albedi FM. Adenosquamous carcinoma of the stomach: histological, histochemical and ultrastructural observations. Histopathology. 1983;7:433–43.

    Article  CAS  PubMed  Google Scholar 

  166. Straus R, Heschel S, Fortmann DJ. Primary adenosquamous carcinoma of the stomach. A case report and review. Cancer. 1969;24:985–95.

    Article  CAS  PubMed  Google Scholar 

  167. Davidson C. Chorioepithelium and Magekrebs, eine seltene Verschmelzung zweier bosartiger Geschwulste. Charite Ann. 1905;29:12.

    Google Scholar 

  168. Kobayashi A, Hasebe T, Endo Y, et al. Primary gastric choriocarcinoma: two case reports and a pooled analysis of 53 cases. Gastric Cancer. 2005;8:178–85.

    Article  PubMed  Google Scholar 

  169. Yoon JH, Kim MS, Kook EH, et al. Primary gastric choriocarcinoma: two case reports and review of the literatures. Cancer Res Treat. 2008;40:145–50.

    Article  PubMed  PubMed Central  Google Scholar 

  170. Satake N, Chikakiyo M, Yagi T, et al. Gastric cancer with choriocarcinoma and yolk sac tumor components: case report. Pathol Int. 2011;61:156–60.

    Article  PubMed  Google Scholar 

  171. Hirano Y, Hara T, Nozawa H, et al. Combined choriocarcinoma, neuroendocrine cell carcinoma and tubular adenocarcinoma in the stomach. World J Gastroenterol. 2008;14:3269–72.

    Article  PubMed  PubMed Central  Google Scholar 

  172. Motoyama T, Aizawa K, Fujiwara T, et al. Coexistence of choriocarcinoma and hepatoid adenocarcinoma in the stomach. Pathol Int. 1994;44:716–21.

    Article  CAS  PubMed  Google Scholar 

  173. Garcia RL, Ghali VS. Gastric choriocarcinoma and yolk sac tumour in a man: observations about its possible origin. Hum Pathol. 1985;16:955–8.

    Article  CAS  PubMed  Google Scholar 

  174. Gurzu S, Copotoiu C, Tugui A, et al. Primary gastric choriocarcinoma – a rare and aggressive tumor with multilineage differentiation: a case report. World J Clin Cases. 2019;7:1837–43.

    Article  PubMed  PubMed Central  Google Scholar 

  175. Masuda R, Isoyama T, Bandou T, et al. A primary choriocarcinoma of the stomach with a review of 45 cases in Japan. Gan No Rinsho. 1990;36:1025–30.

    CAS  PubMed  Google Scholar 

  176. Tomita K, Kuwajima M. Chorionic gonadotropin in gastric cancer tissue, especially its relation to the patient’s prognosis. Gan No Rinsho. 1981;27:2.

    Google Scholar 

  177. Yakeishi Y, Mori M, Enjoji M. Distribution of beta-human chorionic gonadotropin-positive cells in noncancerous gastric mucosa and in malignant gastric tumours. Cancer. 1990;66:695–701.

    Article  CAS  PubMed  Google Scholar 

  178. Pick L. Uber die chorioepthelahnlich metastsierende from desmagencarcinomas. Klin Wochenscher. 1926;5:1.

    Google Scholar 

  179. Liu AY, Chan WY, Ng EK, et al. Gastric choriocarcinoma shows characteristics of adenocarcinoma and gestational choriocarcinoma: a comparative genomic hybridization and fluorescence in situ hybridization study. Diagn Mol Pathol. 2001;10:161–5.

    Article  CAS  PubMed  Google Scholar 

  180. Nakamura K, Sugano H, Takagi K. Carcinoma of stomach in incipient phase: its histogenesis and histological appearances. Gann. 1968;59:251–8.

    CAS  PubMed  Google Scholar 

  181. Tatematsu M, Ichinose M, Miki K, et al. Gastric intestinal phenotypic expression of human stomach cancers as revealed by pepsinogen immunohistochemistry and mucin histochemistry. Acta Pathol Jpn. 1990;40:494–504.

    CAS  PubMed  Google Scholar 

  182. Kabashima A, Yao T, Tsuneyoshi M. Gastric and intestinal phenotypic expression in the carcinomas and background mucosa of multiple early gastric carcinomas. Histopathol. 2000;37:513–22.

    Article  CAS  Google Scholar 

  183. Yoshino T, Shimoda T, Saitou A, et al. Macroscopic features of differentiated gastric adenocarcinoma with gastric or intestinal phenotype expression in early gastric cancer. Stomach and Intestine. 1999;34:507–25.

    Google Scholar 

  184. Koseki K, Takizawa T, Koike M, et al. Subclassification of well differentiated gastric cancer with reference to biological behavior and malignancy, gastric type vs intestinal type, and papillary carcinoma vs tubular carcinoma. Stomach and Intestine. 1999;34:507–12.

    Google Scholar 

  185. Oya M, Yao T, Tsuneyoshi M. A correlation of intramural invasion with mucin histochemistry, and immunohistochemical expressions of oncogene-related proteins in early gastric carcinoma. Stomach and Intestine. 1997;32:31–9.

    Google Scholar 

  186. Fiocca R, Villani L, Tenti P, et al. Widespread expression of intestinal markers in gastric carcinoma: a light and electron microscopic study using BD-5 monoclonal antibody. J Clin Pathol. 1988;41:178–87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  187. Yao T, Kajiwara M, Kuroiwa S, et al. Malignant transformation of gastric hyperplastic polyps: alteration phenotypes, proliferative activity, and p53 expression. Hum Pathol. 2002;33:1016–22.

    Article  CAS  PubMed  Google Scholar 

  188. Kabashima A, Yao T, Maehara Y, et al. Relationship between biological behavior and phenotypic expression in undifferentiated-type gastric carcinomas. Gastric Cancer. 2005;8:220–7.

    Article  CAS  PubMed  Google Scholar 

  189. Jing H, Geng M, Meng Q, et al. Sarcomatoid carcinoma of the stomach with osteoclast-like giant cells. Tumori. 2012;98:82e–5e.

    Article  PubMed  Google Scholar 

  190. Willems S, Carneiro F, Geboes K. Gastric carcinoma with osteoclast-like giant cells and lymphoepithelioma-like carcinoma of the stomach: two of a kind? Histopathol. 2005;47:320–34.

    Article  Google Scholar 

  191. Agaimy A, Daum O, Markl B, et al. SWI/SNF complex–deficient undifferentiated/rhabdoid carcinomas of the gastrointestinal tract: a series of 13 cases highlighting mutually exclusive loss of SMARCA4 and SMARCA2 and frequent co-inactivation of SMARCB1 and SMARCA2. Am J Surg Pathol. 2016;40:544–53.

    Article  PubMed  Google Scholar 

  192. Agaimy A, Rau TT, Hartmann A, et al. SMARCB1 (INI1)-negative rhabdoid carcinomas of the gastrointestinal tract: clinicopathologic and molecular study of a highly aggressive variant with literature review. Am J Surg Pathol. 2014;38:910–20.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Histopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India

    Kim Vaiphei

Authors
  1. Kim Vaiphei
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kim Vaiphei .

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Vaiphei, K. (2022). Morphological Aspect of Gastric Carcinomas. In: Interpretation of Endoscopic Biopsy - Gastritis, Gastropathies and Beyond. Springer, Singapore. https://doi.org/10.1007/978-981-16-6026-9_15

Download citation

  • DOI: https://doi.org/10.1007/978-981-16-6026-9_15

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-16-6025-2

  • Online ISBN: 978-981-16-6026-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation